- Trujillo J, Yee GC, Haines S. Diabetes Mellitus. In: DiPiro JT, Yee GC, Posey L, Haines ST, Nolin TD, Ellingrod V. DiPiro J.T., & Yee G.C., & Posey L, & Haines S.T., & Nolin T.D., & Ellingrod V(Eds.),Eds. Joseph T. DiPiro, et al.eds. Pharmacotherapy: A Pathophysiologic Approach, 12e. McGraw Hill; 2023. Accessed August 28th, 2023. https://accesspharmacy-mhmedical-com.ezproxy.lib.utexas.edu/content.aspx?bookid=3097§ionid=269398080
- Samson SL, Vellanki P, Blonde L, et. al. Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm- 2023 update. Endocr Pract. 2023 May;29(5):305-340.
- American Diabetes Association. 9. Pharmacologic approaches to glycemic treatment. Diabetes Care. 2023;46 (Suppl 1):S140-157.
- Weinstock RS. General principles of insulin therapy in diabetes mellitus. In: UpToDate, Post TW (Ed), UpToDate, Waltham, MA. (Accessed August 28th, 2023.)
- Weinstock RS. Management of blood glucose in adults with type 1 diabetes mellitus. In: UpToDate, Post TW (Ed), UpToDate, Waltham, MA. (Accessed August 28th, 2023.)
- Levitsky LL, Misra M. Insulin therapy for children and adolescents with type 1 diabetes mellitus. In: UpToDate, Post TW (Ed), UpToDate, Waltham, MA. (Accessed August 28th, 2023.)
- Wexler JW. Insulin therapy in type 2 diabetes mellitus. In: UpToDate, Post TW (Ed), UpToDate, Waltham, MA. (Accessed August 28th, 2023.)
- American Diabetes Association. 6. Glycemic targets: Standards of medical care in diabetes – 2023. Diabetes Care. 2023;46 (Suppl 1): s97-s110.
- American Diabetes Association. 13. Older adults: Standards of medical care in diabetes – 2023. Diabetes Care. 2023;46 (Suppl 1): s216-s229.
- American Diabetes Association. 14. Children and adolescents: Standards of medical care in diabetes – 2023. Diabetes Care. 2023;46 (Suppl 1)S230-S253.
- IBM Micromedex® DRUGDEX® (electronic version). IBM Watson Health, Greenwood Village, Colorado, USA. Available at: https://www-micromedexsolutions-com.libproxy.uthscsa.edu/ (cited: September 6, 2023).
- Clinical Pharmacology [database online]. Tampa, FL: Gold Standard, Inc.; 2021. Available at: http://clinicalpharmacology-ip.com.ezproxy.lib.utexas.edu/. Accessed September 6, 2023.
- Insulin aspart (Fiasp®) package insert. NovoNordisk, June 2023.
- Insulin aspart (NovoLog®) package insert. Novo Nordisk, February 2023.
- Insulin glulisine (Apidra®) package insert. Sanofi-Aventis, July 2023.
- Insulin lispro (Admelog®) package insert. Sanofi-Aventis, November 2020.
- Insulin lispro (Humalog®) package insert. Eli Lilly, August 2023.
- Insulin lispro (Lyumjev®) package insert. Eli Lilly and Company, March 2023.
- Regular insulin (Afrezza®) package insert. MannKind Corporation, February 2023.
- Regular insulin (Humulin® R) package insert. Eli Lilly, January 2023.
- Regular insulin (Humulin® R Concentrated U 500) package insert. Eli Lilly,
June 2022. - Regular insulin (Novolin® R) package insert. Novo Nordisk, November 2022.
- Insulin isophane (NPH) (Humulin® N) package insert. Eli Lilly, March 2023.
- Insulin isophane (NPH) (Novolin® N) package insert. Novo Nordisk, November 2022.
- Insulin degludec (Tresiba®) package insert. Novo Nordisk, July 2022.
- Insulin detemir (Levemir®) package insert. Novo Nordisk, December 2022.
- Insulin glargine (Basaglar®, KwikPen™, Tempo Pen™) package insert. Eli Lilly, June 2023.
- Insulin glargine (Lantus®, Solostar™) package insert. Sanofi-Aventis, June 2023.
- Insulin glargine-aglr (Rezvoglar®, Kwikpen™) package insert. Eli Lilly and Company, November 2022.
- Insulin glargine-yfgn (Semglee®) package insert. Mylan Specialty LP, July 2023.
- Insulin glargine (Toujeo®, Toujeo Max®) package insert. Sanofi-Aventis, March 2023.
- Insulin aspart protamine and insulin aspart (NovoLog® Mix 70/30) package insert. Novo Nordisk, February 2023.
- Insulin isophane (NPH) and regular (Humulin® 70/30) package insert. Eli Lilly, March 2023.
- Insulin isophane (NPH) and regular (Novolin® 70/30) package insert. Novo Nordisk, November 2022.
- Insulin lispro (Humalog® Mix 50/50) package insert. Eli Lilly, July 2023.
- Insulin lispro (Humalog® Mix 75/25) package insert. Eli Lilly, July 2023.
- Insulin glargine and lixisenatide (Soliqua® 100/33) package insert. Sanofi-Aventis, June 2022.
- Insulin degludec and liraglutide (Xultophy® 100/3.6) package insert. Novo Nordisk, July 2023.
- Melillo G. FDA approves Fiasp for children with diabetes. Am J Manag Care. January 6, 2020. Available at: www.ajmc.com/view/fda-approves-fiasp-for-children-with-diabetes. Accessed September 6, 2023.